Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - Pilot Study IM1.

Trial Profile

Keyhole Limpet Hemocyanin in Chronic Hepatitis C and Compensated Cirrhosis - Pilot Study IM1.

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Apr 2013

At a glance

  • Drugs Keyhole limpet haemocyanin (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 20 Mar 2012 Planned number of patients changed from 15 to 45 as reported by European Clinical Trials Database.
    • 20 Mar 2012 New source identified and integrated (European Clinical Trials Database: EudraCT2011-004394-90)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top